Rating History for Mineralys Therapeutics, Inc. (MLYS) by TD Cowen
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/27/2026 | Tara Bancroft | New Coverage | Buy (N/A) |
N/A (N/A) |
27.51 (24.81) |
-9.81% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/27/2026 | Tara Bancroft | New Coverage | Buy (N/A) |
N/A (N/A) |
27.51 (24.81) |
-9.81% | Details |